ViewRay Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Guggenheim Reiterates Buy Rating on ViewRay Inc. (VRAY)
December 3, 2019 9:01 AM ESTGuggenheim analyst Christopher Pasquale reiterated a Buy rating and $8.00 price target on ViewRay Inc. (NASDAQ: VRAY) after the company announced that it has entered into strategic collaborations with both Elekta (EKTAF) and MDT as part of a planned equity financing.
The analyst... More
Baird Reiterates Outperform Rating on ViewRay Inc. (VRAY); 'Financing Monkey Off the Back'
December 3, 2019 8:54 AM ESTBaird analyst Jason Bednar reiterated an Outperform rating and $6.00 price target on ViewRay Inc. (NASDAQ: VRAY) after the company announced proposed financing details, including a $75M raise in which Fosun, Elekta, and Medtronic will participate. As part of their investments, VRAY will partner... More
ViewRay (VRAY) to Resume Trading at 4:30 pm
December 2, 2019 4:14 PM ESTViewRay (NASDAQ: VRAY) to Resume Trading at 4:30 pm
... MoreViewRay (VRAY) Reports Collaborations with Elekta and Medtronic (MDT)
December 2, 2019 4:04 PM ESTViewRay, Inc. (Nasdaq: VRAY) announced today that it has signed a non-binding memorandum of understanding for collaboration with Elekta AB (Nasdaq: EKTA-B.ST) ("Elekta") to advance the knowledge and use of MR-guided radiation therapy. In connection with the collaboration, Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay, subject to the terms and conditions set forth in a commitment agreement.
Additionally, ViewRay has signed a non-binding memorandum of understanding with Medtronic (NYSE: MDT) to enter into a clinical collaboration in an... More
